Quantitative MRI cell tracking of immune cell recruitment to tumors and draining lymph nodes in response to anti-PD-1 and a DPX-based immunotherapy

DPX is a unique T cell activating formulation that generates robust immune responses (both clinically and preclinically) which can be tailored to various cancers via the use of tumor-specific antigens and adjuvants. While DPX-based immunotherapies may act complementary with checkpoint inhibitors, co...

Descripción completa

Detalles Bibliográficos
Autores principales: Tremblay, Marie-Laurence, O’Brien-Moran, Zoe, Rioux, James A., Nuschke, Andrea, Davis, Christa, Kast, W. Martin, Weir, Genevieve, Stanford, Marianne, Brewer, Kimberly D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714509/
https://www.ncbi.nlm.nih.gov/pubmed/33299663
http://dx.doi.org/10.1080/2162402X.2020.1851539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714509/
https://www.ncbi.nlm.nih.gov/pubmed/33299663
http://dx.doi.org/10.1080/2162402X.2020.1851539

Ejemplares similares